SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14C - Other preliminary information statements:
SEC Accession No. 0000950005-96-000759
Filing Date
1996-09-20
Accepted
1996-09-20 00:00:00
Documents
1
Period of Report
1996-10-07
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 PRELIM SCHEDULE 14C PRE 14C 19303
  Complete submission text file 0000950005-96-000759.txt   20650
Mailing Address
Business Address 3832 BAY CENTER PLACE HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14C | Act: 34 | File No.: 000-22570 | Film No.: 96632772
SIC: 2833 Medicinal Chemicals & Botanical Products